- Home
- PHT vs ANIK Comparison
PHT vs ANIK Comparison
Compare PHT & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHT
- ANIK
- Stock Information
- Founded
- PHT 2002
- ANIK 1983
- Country
- PHT United States
- ANIK United States
- Employees
- PHT N/A
- ANIK N/A
- Industry
- PHT Investment Managers
- ANIK Medical/Dental Instruments
- Sector
- PHT Finance
- ANIK Health Care
- Exchange
- PHT Nasdaq
- ANIK Nasdaq
- Market Cap
- PHT 232.7M
- ANIK 258.5M
- IPO Year
- PHT N/A
- ANIK 1993
- Fundamental
- Price
- PHT $7.88
- ANIK $17.39
- Analyst Decision
- PHT
- ANIK Buy
- Analyst Count
- PHT 0
- ANIK 2
- Target Price
- PHT N/A
- ANIK $24.50
- AVG Volume (30 Days)
- PHT 85.5K
- ANIK 58.6K
- Earning Date
- PHT 01-01-0001
- ANIK 03-12-2025
- Dividend Yield
- PHT 8.76%
- ANIK N/A
- EPS Growth
- PHT N/A
- ANIK N/A
- EPS
- PHT 0.98
- ANIK N/A
- Revenue
- PHT N/A
- ANIK $164,168,000.00
- Revenue This Year
- PHT N/A
- ANIK N/A
- Revenue Next Year
- PHT N/A
- ANIK N/A
- P/E Ratio
- PHT $7.71
- ANIK N/A
- Revenue Growth
- PHT N/A
- ANIK 0.52
- 52 Week Low
- PHT $6.41
- ANIK $15.40
- 52 Week High
- PHT $7.60
- ANIK $29.12
- Technical
- Relative Strength Index (RSI)
- PHT 48.90
- ANIK 51.69
- Support Level
- PHT $7.85
- ANIK $17.44
- Resistance Level
- PHT $7.96
- ANIK $18.19
- Average True Range (ATR)
- PHT 0.07
- ANIK 0.50
- MACD
- PHT -0.01
- ANIK -0.02
- Stochastic Oscillator
- PHT 21.43
- ANIK 40.96
About PHT Pioneer High Income Fund Inc.
Pioneer High Income Trust is a closed-end management investment company. Its investment objective is to provide a high level of current income and to seek capital appreciation by investing predominantly in below investment grade (high-yield) debt securities, loans, and preferred stocks.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.